Multiparametric MRI in prostate cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Esen, Tarik ^a   Turkbey, Baris ^b   Patel, Anup ^c   Futterer, Jurgen ^d  

^a KOÇ UNIVERSITY   (Turkey)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CAUSE OF DEATH; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; EDITORIAL; HUMAN; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; SAMPLING ERROR; TRANSRECTAL ULTRASONOGRAPHY; PATHOLOGY; PROSTATE TUMOR; RADIOGRAPHY;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS;

EID: 84919480741     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/296810     Document Type: Editorial

References (15)

1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012," International Journal of Cancer 2014.
2. F. H. Schröder, H. B. Carter,T. Wolters et al., "Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics," European Urology, vol. 53, no. 3, pp. 468-477, 2008.
3. W. Siu, R. L. Dunn, R. B. Shah, and J. T. Wei, "Use of extended pattern technique for initial prostate biopsy," The Journal of Urology, vol. 174, no. 2, pp. 505-509, 2005.
4. P. Mufarrij, A. Sankin, G. Godoy, and H. Lepor, "Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy," Urology, vol. 76,no. 3, pp.689-692, 2010.
5. E. C. Serefoglu, S. Altinova, N. S. Ugras, E. Akincioglu, E. Asil, and M. D. Balbay, "How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?" Canadian Urological Association Journal, pp. 1-6, 2012.
6. M. A. Bjurlin, H. B. Carter, P. Schellhammer et al., "Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing," The Journal of Urology, vol. 189, no. 6, pp. 2039-2046, 2013.
7. B. Turkbey, P. A. Pinto, H. Mani et al., "Prostate cancer: value of multiparametric MR imaging at 3 T for detection- histopathologic correlation," Radiology, vol. 255, no. 1, pp. 89- 99, 2010.
8. B. Turkbey, P. S. Albert,K.Kurdziel, and P. L.Choyke, "Imaging localized prostate cancer: current approaches and new developments," American Journal of Roentgenology, vol. 192, no. 6, pp. 1471-1480, 2009.
9. J. O. Barentsz, J. Richenberg, R. Clements et al., "ESUR prostate MR guidelines 2012," European Radiology, vol. 22,no. 4, pp.746- 757, 2012.
10. N. Numao, S. Yoshida, Y. Komai et al., "Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer," The Journal of Urology, vol. 190, no. 2, pp. 502-508, 2013.
11. C. M. A. Hoeks, M. G. Schouten, J. G. R. Bomers et al., "Three-teslamagnetic resonance-guided prostate biopsy inmen with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers," European Urology, vol. 62, no. 5, pp. 902-909, 2012.
12. H. A. Vargas, O. Akin, A. Afaq et al., "Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer," The Journal of Urology, vol. 188, no. 5, pp. 1732-1738, 2012.
13. J. S.Wysock, A. B. Rosenkrantz, W. C. Huang et al., "A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial," European Urology, vol. 66, no. 2, pp. 343-351, 2014.
14. V. Panebianco, F. Barchetti, A. Sciarra et al., "Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging," European Radiology, vol. 23, no. 6, pp. 1745-1752, 2013.
15. C. K. Kim, B. K. Park, and H. M. Lee, "Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI," Journal of Magnetic Resonance Imaging, vol. 29, no. 2, pp. 391-397, 2009.